Laboratory Corp. Of America Holdings LH

NYS: LH | ISIN: US50540R4092   12/12/2025
264,18 USD (-0,21%)
(-0,21%)   12/12/2025

24 november 2025 · Labcorp Appoints Victor Bulto to Board of Directors · Persbericht

19 november 2025 · Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research · Persbericht

28 oktober 2025 · Labcorp Announces 2025 Third Quarter Results · Persbericht

23 oktober 2025 · Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings · Persbericht

8 oktober 2025 · Labcorp Declares Quarterly Dividend · Persbericht

30 september 2025 · Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities · Persbericht

25 september 2025 · Labcorp to Announce Third Quarter Financial Results on October 28, 2025 · Persbericht

15 september 2025 · Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses · Persbericht

27 augustus 2025 · Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference · Persbericht

18 augustus 2025 · Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease · Persbericht

30 juli 2025 · Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search · Persbericht

29 juli 2025 · Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU · Persbericht

24 juli 2025 · Labcorp Announces 2025 Second Quarter Results · Persbericht

10 juli 2025 · Labcorp Declares Quarterly Dividend · Persbericht

26 juni 2025 · Labcorp to Announce Second Quarter Financial Results on July 24, 2025 · Persbericht

18 juni 2025 · Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care · Persbericht

30 mei 2025 · Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research · Persbericht

8 mei 2025 · Labcorp to Webcast Its Annual Meeting of Shareholders May 15 · Persbericht

29 april 2025 · Labcorp Announces 2025 First Quarter Results · Persbericht

23 april 2025 · Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions · Persbericht

Mijn selecties